معلومات عن هذه الحلقة
In this FAQ video module, Tiffany Terrell, NP, reviews the role of early intervention and steroid reduction in minimizing long-term organ damage in systemic lupus erythematosus (SLE) and lupus nephritis. This overview highlights the importance of timely treatment, routine kidney monitoring, and controlling inflammation while limiting prolonged corticosteroid exposure.
This episode explores American College of Rheumatology (ACR) recommendations for lupus management, including monitoring for kidney involvement and tapering glucocorticoids as disease activity comes under control. Tiffany also discusses the risks associated with long-term, high-dose steroid use, including infections, osteoporosis, glaucoma, and avascular necrosis. The discussion emphasizes the balance between maintaining disease control and reducing treatment-related complications to support long-term outcomes for patients with lupus.
Designed for rheumatology advanced practice providers, nurse practitioners, physician assistants, and other clinicians managing lupus and lupus nephritis, this module highlights the importance of proactive monitoring, early treatment, and individualized steroid reduction. For more rheumatology education and clinical resources, visit RhAPP’s website, the RhAPP Content Rheum, or the RhAPP ACE app.
